Good morning, one and all. Damian Garde here, filling in for Ed Silverman at Pharmalot’s satellite campus. It is, as you undoubtedly know, the end of yet another working week, which of course means all the assorted indignities of a laboring life will soon fade into the weekend. As always, we hope you have plans to make the most of your reprieve, however brief. In the meantime, please find a few tidbits to get you started this fine Friday. And if you hear anything that raises your eyebrow, do let us know.
Sanofi is replacing CEO Olivier Brandicourt with an executive from Novartis, Reuters reports. On Sept. 1, Novartis’s Paul Hudson will take over the French drug maker. Hudson, who joined Novartis in 2016, has led the Swiss company’s pharmaceutical division. Brandicourt will retire after four years in charge of Sanofi.